April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Intravitreal Injections Of Linezolid To Treat Experimental S. Aureus Endophthalmitis
Author Affiliations & Notes
  • Maher Saleh
    Ophthalmology, Univ Hosp of Strasbourg, Strasbourg, France
    Department of Microbiology, University Hospital of Strasbourg, France
  • Sophie Lefevre
    Ophthalmology, Univ Hosp of Strasbourg, Strasbourg, France
  • Francois Jehl
    Department of Microbiology, University Hospital of Strasbourg, France
  • Gilles Prevost
    Department of Microbiology, University Hospital of Strasbourg, France
  • David Gaucher
    Ophthalmology, Univ Hosp of Strasbourg, Strasbourg, France
  • Arnaud Sauer
    Ophthalmology, Univ Hosp of Strasbourg, Strasbourg, France
  • Claude Speeg
    Ophthalmology, Univ Hosp of Strasbourg, Strasbourg, France
  • Tristan Bourcier
    Ophthalmology, Univ Hosp of Strasbourg, Strasbourg, France
  • Footnotes
    Commercial Relationships  Maher Saleh, None; Sophie Lefevre, None; Francois Jehl, None; Gilles Prevost, None; David Gaucher, None; Arnaud Sauer, None; Claude Speeg, None; Tristan Bourcier, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2933. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maher Saleh, Sophie Lefevre, Francois Jehl, Gilles Prevost, David Gaucher, Arnaud Sauer, Claude Speeg, Tristan Bourcier; Intravitreal Injections Of Linezolid To Treat Experimental S. Aureus Endophthalmitis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2933.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the effects of intravitreal linezolid in an experimental rabbit model of Staphylococcus aureus endophthalmitis.

Methods: : The right eyes of 22 rabbits weighing 2.5 to 3 kg were used. Ten thousand colony-forming units (CFU) of S. aureus in 0.1 ml saline solution were inoculated into the vitreous cavity. The eyes were randomly assigned to one of the five groups of 4, equally. Twenty-four hours after the inoculation of S. aureus, group 1 received 0.2 mg, group 2 received 1mg, group 3 received 10mg and group 4 received 30 mg of linezolid, while groupe 5 received 1 mg of vancomycin. The two remaining animals received Sham injections. Clinical examination scores were recorded everyday. Vitreous aspirates were obtained 1, 5, and 8 days after the inoculation for microbiological analysis. The eyes were enucleated for histopathologic examination at day 8. Statistical analysis was performed using Kruskal-Wallis and Mann-Whitney U tests.

Results: : Group 4 was the only one to display equal efficacy with the vancomycin group. Number of CFU and histopathologic score in this group were significantly lower compared with other linezolid groups (p < 0.05).

Conclusions: : Intravitreal injection of linezolid in treating S. aureus endophthalmitis was only effective at high dose (30 mg). Caution should be taken in proposing linezolid for Gram + endophthalmitis.

Keywords: endophthalmitis • antibiotics/antifungals/antiparasitics • injection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×